144 results
Page 3 of 8
424B5
ufbl6hfot7ttqlcryi
29 Mar 12
Prospectus supplement for primary offering
12:00am
424B5
oin9p58mnm36rra2e1pg
29 Mar 12
Prospectus supplement for primary offering
12:00am
8-K
EX-99.3
wva25qb0wv
6 Jan 12
NeoStem, Inc. (“NBS”) Investor Presentation January 2012
12:00am
8-K
EX-4.1
0e2qek
17 Oct 11
NeoStem Acquires Amorcyte, a Clinical Stage Cardiovascular Disease Cell Therapy Company
12:00am
424B5
goso i3hk
30 Sep 11
Prospectus supplement for primary offering
12:00am
424B3
fuwkx09m
16 Sep 11
Prospectus supplement
12:00am
8-K
EX-4.1
jlhtzfp
20 Jul 11
NeoStem Announces Pricing of Public Offering for $16,500,000 in Gross Proceeds
12:00am
425
EX-4.1
jdyrp5
20 Jul 11
Business combination disclosure
12:00am
424B5
2qbv2bt8rw z8g8qks
20 Jul 11
Prospectus supplement for primary offering
12:00am
424B5
bk32w4 dceu
18 Jul 11
Prospectus supplement for primary offering
12:00am
425
70158l8j
14 Jul 11
Business combination disclosure
12:00am
8-K
EX-2.1
g6c8sx5mcu5odki kixb
14 Jul 11
Entry into a Material Definitive Agreement
12:00am
8-K
h596vfp j6195
14 Jul 11
Entry into a Material Definitive Agreement
12:00am
425
EX-2.1
zpfqmucp
14 Jul 11
Business combination disclosure
12:00am